Cytosorbents Corporation
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 74.4% | -52.7% | -56.9% |
| FY2022 | 59.8% | -90.9% | -94.6% |
| FY2023 | 70.6% | -102.8% | -94.1% |
| FY2024 | 69.9% | -46.2% | -58.2% |
| FY2025 | 71.5% | -39.8% | -22.1% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 74.4% | -52.7% | -56.9% |
| FY2022 | 59.8% | -90.9% | -94.6% |
| FY2023 | 70.6% | -102.8% | -94.1% |
| FY2024 | 69.9% | -46.2% | -58.2% |
| FY2025 | 71.5% | -39.8% | -22.1% |